Related Experiment Video
Updated: Jun 21, 2026
09:48
Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Striatal neuroprotection with methylene blue
J C Rojas1, N Simola, B A Kermath
1Institute for Neuroscience, University of Texas at Austin, Austin, TX, USA.
Neuroscience
|July 15, 2009
Summary
Methylene Blue (MB) protects against rotenone-induced neurotoxicity in rats by reducing brain damage, preserving metabolic function, and improving motor deficits. This highlights MB
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Low-dose Methylene Blue (MB) shows potential in preventing neurotoxin-induced neural damage.
- Rotenone (Rot) is a neurotoxin that causes damage to neural pathways.
- Oxidative stress and impaired energy metabolism are key factors in neurodegeneration.
Purpose of the Study:
- To evaluate Methylene Blue's neuroprotective effects against rotenone-induced striatal damage in rats.
- To assess MB's impact on anatomical, metabolic, and functional outcomes following rotenone infusion.
Main Methods:
- Stereological analysis of striatal lesion volumes.
- Cytochrome oxidase histochemistry to map oxidative energy metabolism.
- Measurement of oxidative stress markers.
- Behavioral tests to assess motor asymmetry.
Main Results:
- Methylene Blue significantly reduced the size of rotenone-induced striatal lesions.
- MB preserved cytochrome oxidase activity and reduced oxidative stress in the striatum.
- MB prevented metabolic deficits in connected motor regions and maintained functional connectivity.
- MB partially ameliorated behavioral sensorimotor deficits.
Conclusions:
- Methylene Blue demonstrates significant neuroprotective effects against rotenone-induced neurotoxicity in the rat striatum.
- MB counteracts anatomical damage, metabolic dysfunction, and functional impairments.
- These findings support Methylene Blue as a potential therapeutic agent for neurodegenerative conditions involving oxidative stress and energy hypometabolism.
